Searched for
MODERNA S CEO
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
US FDA reverses course, will review Moderna's revised flu vaccine applicationThe US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to trial design is...
Moderna plans to lay off 10% of workforce to cut costsModerna is set to reduce its global workforce by roughly 10%, aiming for under 5,000 employees by year's end, as it accelerates cost-cuttin...
Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkModerna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...
US FDA approves Moderna's next-gen COVID vaccine for adults 65 or olderModerna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement under stricte...
Big blow to Moderna vaccine projects as Trump cancels over $700 million fundingThe Trump administration has slashed $766 million allocated in funding to Moderna Inc., an American biotech and pharmaceutical company resp...
mRNA technology-based Cancer vaccine boosts chances of survival: ModernaData revealed that using Merck's immunotherapy drug in combination with high-risk patients decreased their risk of dying.
Moderna open to supplying COVID vaccines to China, CEO says"We are open, we have the capacity" Bancel said about supplying its mRNA-based shots to the country, declining to say whether Moderna had s...
Moderna seeks FDA approvals for its vaccine for kids under 6Now that kids under 6 are the only strata of population that still does not have a vaccine, this move by Moderna might just be the final pi...
Pfizer, BioNTech, Moderna making $1,000 profit every second: AnalysisThe Alliance estimates that the trio will make pre-tax profits of $34 billion this year between them, which works out to over $1,000 a seco...
Moderna finds that inventing a COVID-19 vaccine was the easy partModerna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...
Moderna COVID-19 shot could start being used in children, teens 'within weeks,' CEO saysModerna plans to apply for separate U.S. regulatory clearance in children ages 6 through 11 "very soon," Bancel said, adding that he is hop...
Moderna seeks approval of Covid-19 vaccine for teens in Europe, Canada"We are encouraged that the Moderna Covid-19 vaccine was highly effective at preventing Covid-19 and SARS-CoV-2 infection in adolescents," ...
Moderna vaccine 96 percent effective in 12-17 year-olds, study showsThe study "showed vaccine efficacy against COVID-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identifi...
Moderna CEO says world faces 2022 COVID vaccine production surplusSpeaking at a virtual event on vaccine manufacturing, Stephane Bancel said that additional technology transfers might dent their ability to...
Moderna says its vaccine works against variants, developing booster shotPfizer, which makes a similar COVID-19 vaccine, has previously reported that its shot also appears effective against the strain from Britai...
Moderna to charge $25-$37 for COVID-19 vaccine: CEOOn Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions...
EU says could approve Pfizer and Moderna coronavirus vaccines this yearThe Amsterdam-based EMA will have to study test results before recommending that Brussels gives its approval, but -- speaking after talks w...
US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...
This $5 billion startup made its first Cancer vaccine - for just one personNovel cancer drugs often come with six-figure price tags, so success could be lucrative. Numerous companies are chasing a cancer vaccine. O...